
Chartanalyse Cooper Companies: Qualitätsaktie im Aufwind
Die Aktie bietet mittelfristig fast 30 % Potenzial.
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

Die Aktie bietet mittelfristig fast 30 % Potenzial.
Cooper Companies beats Q2 EPS and sales estimates as CooperVision and CooperSurgical hit record revenues, even with a GAAP loss from recall litigation.
Although the revenue and EPS for The Cooper Companies (COO) give a sense of how its business performed in the quarter ended April 2026, it might be worth considering how some...
The Cooper Companies (COO) delivered earnings and revenue surprises of +9.67% and +2.57%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what...
Image source: The Motley Fool.DATEWednesday, May 20, 2026 at 9 a.m. ETCALL PARTICIPANTSChairman, President, and Chief Executive Officer — Marvin EllisonExecutive Vice President,...